GO:0060052 neurofilament cytoskeleton organization: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060052 neurofilament cytoskeleton organization describes the cellular process that assembles, arranges, and disassembles neurofilaments and their associated proteins.
• Neurofilaments are neuron-specific intermediate filaments that provide structural support to axons and regulate axonal caliber.
• Disruption of neurofilament organization is linked to neurodegenerative diseases, traumatic brain injury, and axonal degeneration.
• Key genes include NEFL, NEFM, NEFH, INA, and associated proteins such as STMN2, which regulate neurofilament dynamics.
• Experimental models for studying this process include knockout, knock-in, and overexpression cell lines, as well as CRISPR library screening.
• Understanding neurofilament cytoskeleton organization is critical for developing therapies for motor neuron diseases and neurotrauma.
Description
Neurofilament cytoskeleton organization (GO:0060052) is a biological process that governs the assembly, arrangement, and disassembly of neurofilaments and their associated proteins within cells. Neurofilaments are intermediate filaments predominantly expressed in neurons, where they form the major cytoskeletal component of axons and regulate axonal diameter, which is essential for efficient nerve conduction. This process is fundamental for neuronal development, maintenance, and regeneration, and its dysregulation is implicated in a range of neurological disorders. Researchers study neurofilament cytoskeleton organization to understand how neurons maintain structural integrity and how defects contribute to disease. The process involves the coordinated action of neurofilament subunit proteins (NEFL, NEFM, NEFH), interacting proteins such as internexin (INA), and regulatory factors like stathmin-2 (STMN2). Advances in CRISPR gene editing and high-throughput screening have enabled precise interrogation of the genes and pathways controlling neurofilament organization, offering new insights into neurobiology and disease mechanisms.
neurofilament cytoskeleton organization At A Glance
| GO ID | GO:0060052 |
|---|---|
| GO term | neurofilament cytoskeleton organization |
| Ontology | biological_process |
| Synonym | neurofilament cytoskeleton organisation; neurofilament cytoskeleton organization and biogenesis |
| Major function | Assembly, arrangement, and disassembly of neurofilaments and associated proteins |
| Cellular location | Cytoskeleton, axon, neuronal cytoplasm |
| Key proteins | NEFL, NEFM, NEFH, INA, STMN2 |
| Associated diseases | Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, traumatic brain injury |
| Research methods | CRISPR knockout/knock-in, overexpression, imaging, proteomics |
What Is GO:0060052?
According to the Gene Ontology, GO:0060052 neurofilament cytoskeleton organization is defined as a process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising neurofilaments and their associated proteins. In simpler terms, it encompasses all the cellular activities that build, organize, and break down the neurofilament network, ensuring proper neuronal structure and function.
Why Is neurofilament cytoskeleton organization Important in Cell Biology?
Neurofilament cytoskeleton organization is essential for neuronal structure and function, as neurofilaments determine axonal caliber and mechanical stability, which are critical for rapid nerve impulse propagation. Disruption of this process leads to axonal degeneration and is a hallmark of several neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth disease. Moreover, neurofilament proteins are released into cerebrospinal fluid and blood upon axonal injury, serving as biomarkers for traumatic brain injury and neurodegeneration. Thus, understanding the molecular mechanisms of neurofilament organization has direct implications for diagnosing and treating neurological disorders.
• Maintains axonal caliber and structural integrity of neurons.
• Regulates axonal transport and nerve conduction velocity.
• Dysregulation is linked to neurodegenerative diseases such as ALS and CMT.
• Neurofilament release is a biomarker for traumatic brain injury.
• Involved in neuronal development and regeneration.
• Provides targets for therapeutic intervention in neurotrauma and neurodegeneration.
• Serves as a model for studying intermediate filament assembly and dynamics.
• CRISPR screens can identify novel regulators of neurofilament organization.
What Happens During neurofilament cytoskeleton organization?
Neurofilament subunit synthesis and stoichiometry
In simple terms: The cell produces the building blocks of neurofilaments in the right amounts.
Neurofilaments are composed of three subunit proteins: light (NEFL), medium (NEFM), and heavy (NEFH) neurofilament polypeptides, along with alpha-internexin (INA) in some neurons. The synthesis of these subunits is tightly regulated to maintain proper stoichiometry, as imbalances can lead to filament aggregation or disorganization. This step is critical for the subsequent assembly of the neurofilament network.
Assembly of neurofilament polymers
In simple terms: The building blocks link together to form long filaments.
Neurofilament subunits co-assemble into 10-nm intermediate filaments through a process involving dimer formation, tetramer assembly, and higher-order polymerization. This assembly is driven by hydrophobic interactions between coiled-coil domains and is modulated by phosphorylation of the tail domains, particularly in NEFH and NEFM. The resulting filaments form a stable network that extends along the axon.
Arrangement and cross-linking with other cytoskeletal elements
In simple terms: The filaments are organized and connected to other structural components.
Once assembled, neurofilaments are arranged into parallel bundles and cross-linked to microtubules and actin filaments via associated proteins such as BPAG1 and plectin. This cross-linking provides mechanical strength and maintains axonal architecture. Phosphorylation of neurofilament side arms regulates spacing between filaments, which directly influences axonal diameter.
Disassembly and turnover
In simple terms: Old or damaged filaments are broken down and removed.
Neurofilament disassembly and turnover are mediated by proteases (e.g., calpain) and ubiquitin-proteasome system components. This process is essential for axonal remodeling during development and after injury. Dysregulation of disassembly can lead to neurofilament accumulation, a pathological hallmark of several neurodegenerative diseases.
Regulation by stathmin-2 and other factors
In simple terms: Specific proteins control when and where filaments are built or broken down.
Stathmin-2 (STMN2) has emerged as a critical regulator of neurofilament organization; its loss leads to neurofilament-dependent axonal collapse and denervation. Other regulators include kinases (e.g., CDK5, GSK3β) that phosphorylate neurofilament tail domains, and phosphatases that reverse these modifications. These regulatory mechanisms ensure dynamic control of the neurofilament cytoskeleton in response to developmental and environmental cues.
Key Genes Involved in GO:0060052 neurofilament cytoskeleton organization
The following genes encode proteins that are directly involved in or regulate neurofilament cytoskeleton organization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NEFL | Light neurofilament subunit; core filament assembly | Mutations cause Charcot-Marie-Tooth disease; KO models show axonal defects |
| NEFM | Medium neurofilament subunit; regulates filament spacing | Phosphorylation affects axonal caliber; implicated in ALS |
| NEFH | Heavy neurofilament subunit; cross-linking and spacing | Mutations linked to ALS; key for axonal diameter |
| INA | Alpha-internexin; co-assembles with neurofilaments | Modulates filament network in developing neurons |
| STMN2 | Microtubule and neurofilament regulator | Loss causes axonal collapse; linked to ALS and neuropathy |
| PRPH | Peripherin; intermediate filament in peripheral neurons | Involved in axonal regeneration and degeneration |
| CDK5 | Kinase phosphorylating neurofilament tail domains | Regulates neurofilament dynamics; implicated in neurodegeneration |
| GSK3B | Kinase phosphorylating neurofilaments | Modulates filament stability; linked to Alzheimer's disease |
| MAP1B | Microtubule-associated protein; cross-links neurofilaments | Required for axonal development |
| BPAG1 | Plakin family cross-linker | Connects neurofilaments to actin and microtubules |
| PLEC | Plectin; cytolinker | Maintains cytoskeletal integrity in neurons and muscle |
| CALPAIN | Calcium-dependent protease | Mediates neurofilament disassembly after injury |
| UBB | Ubiquitin; tags neurofilaments for degradation | Proteasomal turnover of neurofilaments |
| SQSTM1 | Autophagy receptor | Clears aggregated neurofilaments |
| KIF5A | Kinesin motor; transports neurofilaments | Mutations cause hereditary spastic paraplegia |
| DCTN1 | Dynactin subunit; retrograde transport | Links neurofilament transport to motor proteins |
| NEFH | Heavy neurofilament subunit; tail phosphorylation | Biomarker for axonal injury |
| STMN2 | Stathmin-2; regulates microtubule and neurofilament stability | Therapeutic target in ALS |
How Is neurofilament cytoskeleton organization Regulated?
Neurofilament cytoskeleton organization is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with other cytoskeletal networks. Phosphorylation of neurofilament tail domains by kinases such as CDK5 and GSK3β modulates filament spacing and axonal caliber. The integrated stress response (ISR) and mTOR signaling can influence neurofilament synthesis and assembly, particularly under stress conditions. Additionally, stathmin-2 (STMN2) acts as a key regulator; its downregulation leads to neurofilament-dependent axonal collapse, highlighting its role in maintaining cytoskeletal integrity. These regulatory mechanisms ensure that neurofilament organization is dynamically adjusted during development, injury, and disease.
neurofilament cytoskeleton organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NEFL | Charcot-Marie-Tooth disease | Knockout or point-mutation iPSC-derived neurons |
| NEFH | Amyotrophic lateral sclerosis | Knock-in mouse models or patient-derived organoids |
| STMN2 | ALS, axonal collapse | CRISPR knockout in motor neurons; overexpression rescue |
| NEFM | Neurodegeneration, axonal caliber defects | Overexpression and knockout cell lines |
| INA | Neuronal development disorders | Knockout zebrafish or mouse models |
Neurodegenerative diseases
Disruption of neurofilament cytoskeleton organization is a common feature of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), and Alzheimer's disease. Mutations in NEFL cause CMT, while NEFH mutations are associated with ALS. In ALS, loss of STMN2 leads to neurofilament-dependent axonal collapse and motor neuron degeneration. These findings underscore the importance of proper neurofilament organization for neuronal survival.
Traumatic brain injury
Traumatic brain injury (TBI) causes rapid release of neurofilament proteins into the cerebrospinal fluid and blood, reflecting axonal damage. The degree of neurofilament disorganization correlates with injury severity and clinical outcome. Thus, neurofilament cytoskeleton organization is not only a structural process but also a source of biomarkers for neurotrauma.
Peripheral neuropathies
Peripheral neuropathies, including those caused by chemotherapy or diabetes, often involve neurofilament disorganization and axonal degeneration. Animal models with altered neurofilament subunit expression display peripheral nerve defects, highlighting the role of neurofilament organization in maintaining peripheral nerve function.
From neurofilament cytoskeleton organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NEFL disrupt neurofilament assembly? | NEFL knockout cell line (e.g., SH-SY5Y) or iPSC-derived neurons |
| How do disease-associated point mutations affect filament stability? | CRISPR point-mutation knock-in in neuroblastoma cells |
| Can overexpression of STMN2 rescue axonal collapse? | STMN2 overexpression in STMN2-knockout motor neurons |
| What is the role of NEFH phosphorylation in axonal caliber? | Phospho-mutant knock-in mice or cell lines |
| Which genes regulate neurofilament organization? | Genome-wide CRISPR knockout library screening in neuronal cells |
| How does traumatic injury affect neurofilament network? | In vitro stretch injury model in primary neurons |
How to Study the neurofilament cytoskeleton organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Neurofilament network morphology | Visualizing filament bundling and axonal caliber |
| Live-cell imaging | Dynamic assembly/disassembly | Tracking neurofilament transport in neurons |
| Co-immunoprecipitation + MS | Protein interactions | Identifying novel neurofilament-associated proteins |
| Phosphoproteomics | Phosphorylation sites | Mapping regulatory modifications on NEFH/NEFM |
| CRISPR knockout screen | Gene function | Discovering regulators of neurofilament organization |
| RNA-seq | Transcriptional changes | Measuring neurofilament gene expression |
| Ribo-seq | Translational efficiency | Assessing neurofilament mRNA translation |
| Proximity ligation assay | In situ protein interactions | Detecting neurofilament cross-linkers |
Imaging-based methods
Fluorescence microscopy, including confocal and super-resolution imaging, allows visualization of neurofilament network organization in fixed and live cells. Immunostaining with antibodies against NEFL, NEFM, and NEFH reveals filament distribution and bundling. Live-cell imaging using GFP-tagged neurofilament subunits enables tracking of assembly and transport dynamics.
Biochemical and proteomic approaches
Co-immunoprecipitation and mass spectrometry can identify neurofilament-associated proteins and post-translational modifications. Phosphoproteomics reveals site-specific phosphorylation of neurofilament tail domains, which regulates filament spacing. These methods are essential for mapping the molecular interactome of neurofilaments.
Genetic and CRISPR screening
CRISPR knockout and activation screens can systematically identify genes that regulate neurofilament organization. For example, a genome-wide screen in neuronal cells may uncover novel regulators of neurofilament bundling or turnover. Such screens are powerful for discovering therapeutic targets in neurodegeneration.
Transcriptomic and translational profiling
RNA-seq and Ribo-seq measure mRNA expression and translation efficiency of neurofilament genes and associated factors. These techniques can reveal how neurofilament organization is regulated at the transcriptional and translational levels under stress or disease conditions.
How CRISPR Can Be Used to Study GO:0060052 neurofilament cytoskeleton organization
Knockout
CRISPR knockout of neurofilament genes (e.g., NEFL, NEFM, NEFH) or regulators (e.g., STMN2) in neuronal cell lines or iPSC-derived neurons can reveal their essential roles in filament assembly and axonal stability. Knockout models often display disrupted neurofilament networks and impaired axonal transport.
Point Mutation
Introducing disease-associated point mutations (e.g., NEFL mutations found in CMT) via CRISPR base editing or homology-directed repair allows study of how specific amino acid changes affect neurofilament assembly and function. Such models are valuable for understanding genotype-phenotype relationships.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous neurofilament genes enables real-time tracking of filament dynamics and interaction partners. This approach preserves endogenous regulation and is ideal for imaging studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of neurofilament subunits or regulators (e.g., STMN2) can rescue loss-of-function phenotypes or model neurofilament accumulation. Overexpression models help dissect dosage effects and identify therapeutic targets.
How EDITGENE Supports neurofilament cytoskeleton organization Research
Researchers studying neurofilament cytoskeleton organization-related genes often need to determine whether a candidate gene is causally involved in filament assembly, maintenance, or disassembly. This requires precise genetic manipulation and functional validation in relevant neuronal models. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such discoveries, from knockout to knock-in and high-throughput screening.
Contact EDITGENE today to design your custom CRISPR model for neurofilament cytoskeleton organization research.
Frequently Asked Questions About neurofilament cytoskeleton organization
What is GO:0060052 neurofilament cytoskeleton organization?
It is a biological process that encompasses the assembly, arrangement, and disassembly of neurofilaments and their associated proteins, as defined by the Gene Ontology.
What genes are involved in neurofilament cytoskeleton organization?
Key genes include NEFL, NEFM, NEFH, INA, and STMN2, which encode neurofilament subunits and regulatory proteins.
How is neurofilament cytoskeleton organization studied?
Researchers use imaging, proteomics, CRISPR screens, and biochemical assays to study this process.
Why is neurofilament cytoskeleton organization important?
It maintains axonal structure and function; its disruption is linked to neurodegenerative diseases and brain injury.
What diseases are associated with defects in neurofilament organization?
Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, and traumatic brain injury are associated with neurofilament disorganization.
What is the role of STMN2 in neurofilament organization?
STMN2 regulates neurofilament stability; its loss leads to neurofilament-dependent axonal collapse.
Can CRISPR be used to study neurofilament cytoskeleton organization?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise genetic dissection of this process.
What are neurofilaments?
Neurofilaments are neuron-specific intermediate filaments that provide structural support to axons.
How do neurofilaments affect axonal caliber?
Phosphorylation of neurofilament tail domains regulates filament spacing, which determines axonal diameter.
What biomarkers are associated with neurofilament disorganization?
Neurofilament proteins released into CSF and blood are biomarkers for traumatic brain injury and neurodegeneration.
Conclusion
Neurofilament cytoskeleton organization (GO:0060052) is a fundamental biological process that maintains neuronal architecture and function. Its dysregulation is a key contributor to neurodegenerative diseases and neurotrauma, making it a critical area of research. Advances in CRISPR gene editing and high-throughput screening are accelerating the discovery of molecular players and therapeutic targets. EDITGENE provides essential tools and services to support these investigations, from custom knockout models to comprehensive screening and bioinformatics.
References
- 1. Hohmann T et al.. 2019. The Cytoskeleton-A Complex Interacting Meshwork.. Cells 8(4) PMID: 31003495
- 2. Yuan A et al.. 2017. Neurofilaments and Neurofilament Proteins in Health and Disease.. Cold Spring Harb Perspect Biol 9(4) PMID: 28373358
- 3. Blennow K et al.. 2016. Traumatic brain injuries.. Nat Rev Dis Primers 2:16084 PMID: 27853132
- 6. Coulombe PA. 2022. Capturing intermediate filament networks.. Elife 11 PMID: 35377313
- 7. López-Erauskin J et al.. 2024. Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation.. Nat Neurosci 27(1):34-47 PMID: 37996528
